{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T05:24:26Z","timestamp":1769837066153,"version":"3.49.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Translational Medicine"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.retram.2020.09.003","type":"journal-article","created":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T01:59:09Z","timestamp":1602813549000},"page":"103269","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Selective dysregulation of ABC transporters in methotrexate-resistant leukemia T-cells can confer cross-resistance to cytarabine, vincristine and dexamethasone, but not doxorubicin"],"prefix":"10.1016","volume":"69","author":[{"given":"Narges","family":"Aberuyi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1376-255X","authenticated-orcid":false,"given":"Soheila","family":"Rahgozar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elnaz","family":"Pourabutaleb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamran","family":"Ghaedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.retram.2020.09.003_bib0005","first-page":"118","article-title":"The role of ATP-binding cassette transporter A2 in childhood acute lymphoblastic leukemia multidrug resistance","volume":"4","author":"Aberuyi","year":"2014","journal-title":"Iran J Ped Hematol Oncol"},{"key":"10.1016\/j.retram.2020.09.003_bib0010","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.leukres.2018.01.004","article-title":"Association between a microRNA binding site polymorphism in SLCO1A2 and the risk of delayed methotrexate elimination in Chinese children with acute lymphoblastic leukemia","volume":"65","author":"S-m","year":"2018","journal-title":"Leuk Res"},{"key":"10.1016\/j.retram.2020.09.003_bib0015","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/4047617","article-title":"Complications of intrathecal chemotherapy in adults: single-institution experience in 109 consecutive patients","volume":"2019","author":"Byrnes","year":"2019","journal-title":"J Oncol"},{"issue":"6","key":"10.1016\/j.retram.2020.09.003_bib0020","doi-asserted-by":"crossref","first-page":"824","DOI":"10.3390\/cancers11060824","article-title":"Improving the brain delivery of chemotherapeutic drugs in childhood brain tumors","volume":"11","author":"Triarico","year":"2019","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.retram.2020.09.003_bib0025","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13045-015-0158-9","article-title":"Methotrexate resistance in relation to treatment outcome in childhood acute lymphoblastic leukemia","volume":"8","author":"Wojtuszkiewicz","year":"2015","journal-title":"J Hematol Oncol"},{"issue":"2","key":"10.1016\/j.retram.2020.09.003_bib0030","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/sj.leu.2402373","article-title":"Effect of methotrexate polyglutamates on thioguanine nucleotide concentrations during continuation therapy of acute lymphoblastic leukemia with mercaptopurine","volume":"16","author":"Dervieux","year":"2002","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.retram.2020.09.003_bib0035","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/MPH.0000000000000206","article-title":"Mercaptopurine\/methotrexate maintenance therapy of childhood acute lymphoblastic leukemia: clinical facts and fiction","volume":"36","author":"Schmiegelow","year":"2014","journal-title":"J Pediatr Hematol Oncol"},{"issue":"8709","key":"10.1016\/j.retram.2020.09.003_bib0040","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0140-6736(90)91745-V","article-title":"Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia","volume":"336","author":"Lennard","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.retram.2020.09.003_bib0045","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ejps.2016.03.025","article-title":"Cancer chemoresistance; biochemical and molecular aspects: a brief overview","volume":"89","author":"Kachalaki","year":"2016","journal-title":"Eur J Pharm Sci"},{"issue":"8","key":"10.1016\/j.retram.2020.09.003_bib0050","doi-asserted-by":"crossref","first-page":"10021","DOI":"10.1007\/s13277-016-5059-1","article-title":"Mechanisms of tumor cell resistance to the current targeted-therapy agents","volume":"37","author":"Khamisipour","year":"2016","journal-title":"Tumor Biol"},{"issue":"4","key":"10.1016\/j.retram.2020.09.003_bib0055","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1634\/theoncologist.2017-0354","article-title":"Molecular biomarkers of primary and acquired resistance to T\u2010Cell\u2010Mediated immunotherapy in Cancer: landscape, clinical implications, and future directions","volume":"23","author":"Chae","year":"2018","journal-title":"Oncologist"},{"issue":"7","key":"10.1016\/j.retram.2020.09.003_bib0060","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3390\/molecules21070965","article-title":"Targeting epithelial\u2013mesenchymal transition (EMT) to overcome drug resistance in cancer","volume":"21","author":"Du","year":"2016","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.retram.2020.09.003_bib0065","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.cell.2004.07.011","article-title":"Epithelial-mesenchymal transitions: twist in development and metastasis","volume":"118","author":"Kang","year":"2004","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.retram.2020.09.003_bib0070","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3390\/cells9020428","article-title":"Epithelial to mesenchymal transition: a mechanism that fuels Cancer radio\/chemoresistance","volume":"9","author":"Dud\u00e1s","year":"2020","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.retram.2020.09.003_bib0075","doi-asserted-by":"crossref","first-page":"874","DOI":"10.18632\/oncotarget.2716","article-title":"TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancer","volume":"6","author":"Galv\u00e1n","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.retram.2020.09.003_bib0080","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3892\/mco.2012.28","article-title":"Epigenetic control of epithelial-mesenchymal-transition in human cancer","volume":"1","author":"Kiesslich","year":"2013","journal-title":"Mol Clin Oncol"},{"issue":"3","key":"10.1016\/j.retram.2020.09.003_bib0085","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/jmcb\/mjv035","article-title":"Network biology approach to epithelial\u2013mesenchymal transition in cancer metastasis: three stage theory","volume":"7","author":"Tanaka","year":"2015","journal-title":"J Mol Cell Biol"},{"issue":"1","key":"10.1016\/j.retram.2020.09.003_bib0090","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12929-018-0440-6","article-title":"Emerging roles of epithelial-mesenchymal transition in hematological malignancies","volume":"25","author":"Chen","year":"2018","journal-title":"J Biomed Sci"},{"issue":"8","key":"10.1016\/j.retram.2020.09.003_bib0095","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2015.67","article-title":"Favorable clinical outcome and unique characteristics in association with Twist1 overexpression in de novo acute myeloid leukemia","volume":"5","author":"Chen","year":"2015","journal-title":"Blood Cancer J"},{"issue":"8","key":"10.1016\/j.retram.2020.09.003_bib0100","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jcma.2015.05.002","article-title":"Epithelial\u2013mesenchymal transition-related factors in solid tumor and hematological malignancy","volume":"78","author":"Chou","year":"2015","journal-title":"J Chinese Med Assoc"},{"key":"10.1016\/j.retram.2020.09.003_bib0105","article-title":"Ginger extract has anti-leukemia and anti-drug resistant effects on malignant cells","author":"Rahimi","year":"2019","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"10.1016\/j.retram.2020.09.003_bib0110","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12885-016-2071-1","article-title":"Molecular characterization of irinotecan (SN-38) resistant human breast cancer cell lines","volume":"16","author":"Jandu","year":"2016","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.retram.2020.09.003_bib0115","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4161\/cbt.26603","article-title":"mRNA expression profile of multidrug-resistant genes in acute lymphoblastic leukemia of children, a prognostic value for ABCA3 and ABCA2","volume":"15","author":"Rahgozar","year":"2014","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.retram.2020.09.003_bib0120","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.2147\/OTT.S140488","article-title":"The translational expression of ABCA2 and ABCA3 is a strong prognostic biomarker for multidrug resistance in pediatric acute lymphoblastic leukemia","volume":"10","author":"Aberuyi","year":"2017","journal-title":"Onco Targets Ther"},{"issue":"4","key":"10.1016\/j.retram.2020.09.003_bib0125","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/0006-2952(80)90391-3","article-title":"Effects of methotrexate esters and other lipophilic antifolates on methotrexate-resistant human leukemic lymphoblasts","volume":"29","author":"Rosowsky","year":"1980","journal-title":"Biochem Pharmacol"},{"issue":"13","key":"10.1016\/j.retram.2020.09.003_bib0130","first-page":"3514","article-title":"Methotrexate cross-resistance in a mitoxantrone-selected multidrug-resistant MCF7 breast cancer cell line is attributable to enhanced energy-dependent drug efflux","volume":"60","author":"Volk","year":"2000","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.retram.2020.09.003_bib0135","first-page":"150","article-title":"Mechanisms of drug resistance in veterinary oncology\u2014a review with an emphasis on canine lymphoma","volume":"2","author":"Zandvliet","year":"2015","journal-title":"Vet Sci"},{"issue":"5","key":"10.1016\/j.retram.2020.09.003_bib0140","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.3892\/ol.2014.2463","article-title":"Overexpression of the Survivin gene in SGC7901 cell resistance to cisplatin","volume":"8","author":"Dong","year":"2014","journal-title":"Oncol Lett"},{"issue":"1","key":"10.1016\/j.retram.2020.09.003_bib0145","first-page":"11","article-title":"Generation of cisplatin-resistant ovarian cancer cell lines","volume":"12","author":"Nikounezhad","year":"2016","journal-title":"Iranian Journal of Pharmaceutical Sciences."},{"issue":"3","key":"10.1016\/j.retram.2020.09.003_bib0150","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1083\/jcb.200611146","article-title":"Cell size and invasion in TGF-\u03b2\u2013induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway","volume":"178","author":"Lamouille","year":"2007","journal-title":"J Cell Biol"},{"issue":"1","key":"10.1016\/j.retram.2020.09.003_bib0155","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12935-018-0555-6","article-title":"Epithelial to mesenchymal transition induces stem cell like phenotype in renal cell carcinoma cells","volume":"18","author":"Singla","year":"2018","journal-title":"Cancer Cell Int"},{"issue":"7","key":"10.1016\/j.retram.2020.09.003_bib0160","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/1878-0261.12085","article-title":"EMT\u2010and MET\u2010related processes in nonepithelial tumors: importance for disease progression, prognosis, and therapeutic opportunities","volume":"11","author":"Kahlert","year":"2017","journal-title":"Mol Oncol"},{"issue":"25","key":"10.1016\/j.retram.2020.09.003_bib0165","doi-asserted-by":"crossref","first-page":"20977","DOI":"10.18632\/oncotarget.4007","article-title":"TWIST-1 promotes cell growth, drug resistance and progenitor clonogenic capacities in myeloid leukemia and is a novel poor prognostic factor in acute myeloid leukemia","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"issue":"32","key":"10.1016\/j.retram.2020.09.003_bib0170","doi-asserted-by":"crossref","first-page":"52901","DOI":"10.18632\/oncotarget.17548","article-title":"Twist1 confers multidrug resistance in colon cancer through upregulation of ATP-binding cassette transporters","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.retram.2020.09.003_bib0175","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1158\/1078-0432.CCR-08-2372","article-title":"Twist1-mediated adriamycin-induced epithelial-mesenchymal transition relates to multidrug resistance and invasive potential in breast cancer cells","volume":"15","author":"Li","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.retram.2020.09.003_bib0180","first-page":"1058","article-title":"Association between Twist and multidrug resistance gene\u2011associated proteins in Taxol\u00ae\u2011resistant MCF\u20117 cells and a 293 cell model of Twist overexpression","volume":"15","author":"Wang","year":"2018","journal-title":"Oncol Lett"},{"issue":"3","key":"10.1016\/j.retram.2020.09.003_bib0185","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1590\/S1516-31802008000300007","article-title":"Expression of MRP1 gene in acute leukemia","volume":"126","author":"Mahjoubi","year":"2008","journal-title":"Sao Paulo Med J"},{"issue":"1","key":"10.1016\/j.retram.2020.09.003_bib0190","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4103\/1110-1067.124839","article-title":"Evaluation of multidrug resistance in acute leukemia using real-time polymerase chain reaction","volume":"39","author":"Mossad","year":"2014","journal-title":"Egypt J Haematol"},{"key":"10.1016\/j.retram.2020.09.003_bib0195","article-title":"Expression of MDR1, LRP, BCRP and Bcl-2 genes at diagnosis of childhood all: comparison with MRD status after induction therapy","author":"Fedasenka","year":"2008","journal-title":"Exp Oncol"},{"issue":"1","key":"10.1016\/j.retram.2020.09.003_bib0200","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/jcla.21563","article-title":"Importance of detecting multidrug resistance proteins in acute leukemia prognosis and therapy","volume":"27","author":"de Moraes","year":"2013","journal-title":"J Clin Lab Anal"},{"issue":"11","key":"10.1016\/j.retram.2020.09.003_bib0205","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1080\/10428194.2018.1448083","article-title":"Role of Yin Yang-1 (YY1) in the transcription regulation of the multi-drug resistance (MDR1) gene","volume":"59","author":"Antonio-Andr\u00e9s","year":"2018","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"10.1016\/j.retram.2020.09.003_bib0210","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s00277-019-03629-7","article-title":"The role of ABCB1 polymorphism as a prognostic marker for primary central nervous system lymphoma","volume":"98","author":"Wu","year":"2019","journal-title":"Ann Hematol"},{"issue":"3","key":"10.1016\/j.retram.2020.09.003_bib0215","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2217\/pgs-2016-0150","article-title":"ATP-binding casette transporter expression in acute myeloid leukemia: association with in vitro cytotoxicity and prognostic markers","volume":"18","author":"Varatharajan","year":"2017","journal-title":"Pharmacogenomics"},{"issue":"5","key":"10.1016\/j.retram.2020.09.003_bib0220","first-page":"6671","article-title":"Co-expression of ATP binding cassette transporters is associated with poor prognosis in acute myeloid leukemia","volume":"15","author":"Liu","year":"2018","journal-title":"Oncol Lett"},{"issue":"6","key":"10.1016\/j.retram.2020.09.003_bib0225","doi-asserted-by":"crossref","first-page":"4785","DOI":"10.3892\/ol.2017.6049","article-title":"Downregulation of eIF4G by microRNA-503 enhances drug sensitivity of MCF-7\/ADR cells through suppressing the expression of ABC transport proteins","volume":"13","author":"Pan","year":"2017","journal-title":"Oncol Lett"},{"issue":"3","key":"10.1016\/j.retram.2020.09.003_bib0230","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2174\/1568009616666151106120434","article-title":"Targeting ABCB1 and ABCC1 with their specific inhibitor CBT-1\u00ae can overcome drug resistance in osteosarcoma","volume":"16","author":"Fanelli","year":"2016","journal-title":"Curr Cancer Drug Targets"},{"issue":"8","key":"10.1016\/j.retram.2020.09.003_bib0235","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.2217\/pgs.14.68","article-title":"Polymorphisms of the vincristine pathway and response to treatment in children with childhood acute lymphoblastic leukemia","volume":"15","author":"Ceppi","year":"2014","journal-title":"Pharmacogenomics"},{"issue":"2","key":"10.1016\/j.retram.2020.09.003_bib0240","doi-asserted-by":"crossref","first-page":"51","DOI":"10.5732\/cjc.011.10466","article-title":"Role of ABC transporters in cancer chemotherapy","volume":"31","author":"Sun","year":"2012","journal-title":"Chin J Cancer"},{"key":"10.1016\/j.retram.2020.09.003_bib0245","article-title":"Multidrug resistance protein 1 (MRP1, ABCC1): A\u2019Multitasking\u2019ABC transporter","volume":"jbc. R114","author":"Cole","year":"2014","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.retram.2020.09.003_bib0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155013","article-title":"Role of the drug transporter ABCC3 in breast cancer chemoresistance","volume":"11","author":"Balaji","year":"2016","journal-title":"PLoS One"},{"issue":"1-2","key":"10.1016\/j.retram.2020.09.003_bib0255","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1634\/theoncologist.1-1-82","article-title":"Drug resistance","volume":"1","author":"Giaccone","year":"1996","journal-title":"Oncologist"},{"issue":"16","key":"10.1016\/j.retram.2020.09.003_bib0260","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1093\/jnci\/81.16.1250","article-title":"Resistance to drugs associated with the multidrug resistance phenotype following selection with high-concentration methotrexate","volume":"81","author":"Haber","year":"1989","journal-title":"JNCI: Journal of the National Cancer Institute"},{"issue":"6","key":"10.1016\/j.retram.2020.09.003_bib0265","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/sj.leu.2402128","article-title":"High level resistance to glucocorticoids, associated with a dysfunctional glucocorticoid receptor, in childhood acute lymphoblastic leukemia cells selected for methotrexate resistance","volume":"15","author":"Catts","year":"2001","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.retram.2020.09.003_bib0270","first-page":"5286","article-title":"Patterns of cross-resistance to the antifolate drugs trimetrexate, metoprine, homofolate, and CB3717 in human lymphoma and osteosarcoma cells resistant to methotrexate","volume":"43","author":"Diddens","year":"1983","journal-title":"Cancer Res"},{"issue":"13","key":"10.1016\/j.retram.2020.09.003_bib0275","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1182\/blood-2004-04-1493","article-title":"Disparate mechanisms of antifolate resistance provoked by methotrexate and its metabolite 7-hydroxymethotrexate in leukemia cells: implications for efficacy of methotrexate therapy","volume":"104","author":"Fotoohi","year":"2004","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.retram.2020.09.003_bib0280","first-page":"325","article-title":"Cytotoxic effects of folate antagonists against methotrexate-resistant human leukemic lymphoblast CCRF-CEM cell lines","volume":"45","author":"Mini","year":"1985","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.retram.2020.09.003_bib0285","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/(SICI)1097-0215(19981005)78:2<176::AID-IJC10>3.0.CO;2-9","article-title":"P\u2010glycoprotein\u2010mediated methotrexate resistance in CCRF\u2010CEM sublines deficient in methotrexate accumulation due to a point mutation in the reduced folate carrier gene","volume":"78","author":"Gifford","year":"1998","journal-title":"Int J Cancer"}],"container-title":["Current Research in Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318620300581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318620300581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:38:59Z","timestamp":1762821539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452318620300581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S2452318620300581"],"URL":"https:\/\/doi.org\/10.1016\/j.retram.2020.09.003","relation":{},"ISSN":["2452-3186"],"issn-type":[{"value":"2452-3186","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective dysregulation of ABC transporters in methotrexate-resistant leukemia T-cells can confer cross-resistance to cytarabine, vincristine and dexamethasone, but not doxorubicin","name":"articletitle","label":"Article Title"},{"value":"Current Research in Translational Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.retram.2020.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103269"}}